官方服务：
资源简介：
已上架 上市后产品研究报告 针对产品上市后的临床问题，在真实世界环境下收集研究对象使用目标产品后的健康状况、诊疗及保健等相关的数据，并基于这些数据分析获得目标产品的使用价值及潜在获益-风险的临床证据的研究，包括安全性、有效性和经济性的监测和研究。 已上架 挂牌时间：2024-10-17 查看详情
应用场景：
相关数据集
Additional file 3 of Effectiveness of secukinumab in patients with psoriasis and psoriatic arthritis in a Saudi real-world setting
Additional File 3: Pairwise difference in Dermatology Quality of Life Index (DLQI) among PsO and (PsO-PsA) patients from baseline over 12 months receiving Secukinumab (overall and regarding prior use
Figshare2024-08-18 更新50
File S1 - Treatment of Naïve Patients with Chronic Hepatitis C Genotypes 2 and 3 with Pegylated Interferon Alpha and Ribavirin in a Real World Setting: Relevance for the New Era of DAA
In- and exclusion criteria. (DOC)
NIAID Data Ecosystem40
Effectiveness and safety of Ustekinumab for the treatment of Crohn’s disease in real-life experiences: a meta-analysis of observational studies
Background: The aim of this meta-analysis was to estimate the effectiveness and safety of Ustekinumab in Crohn’s disease (CD) reported by observational studies. Research design and methods: PubMed/Me
NIAID Data Ecosystem30
The relative distribution and prevalence of cancer cases by type in the All of Us Research Program from self-reported survey data and electronic health record overall.
The relative distribution and prevalence of cancer cases by type in the All of Us Research Program from self-reported survey data and electronic health record overall.
NIAID Data Ecosystem40
Dataset related to article "Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian landscape psoriasis)"
This record contains raw data related to article “Real life long-term efficacy and safety of ixekizumab in moderate-to-severe psoriasis: A 192 weeks multicentric retrospective study-IL PSO (Italian la
Zenodo2022-11-08 更新30
